Safety of the long-time monthly triple dose of a Gd-based contrast agent.
Sardanelli
Francesco
F
Mancardi
Gianluigi
G
Filippi
Massimo
M
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D003287:Contrast Media / Q000009:adverse effects / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D019786:Gadolinium DTPA / Q000009:adverse effects; D006801:Humans; D008134:Long-Term Care; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D009103:Multiple Sclerosis / Q000175:diagnosis*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D003287:Contrast Media; D019786:Gadolinium DTPA